Utility of aripiprazole in co-occurring problem gambling and toluene dependence: A case report
- 1 October 2018
- journal article
- letter
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 24 (2) , 117-119
Abstract
Inhalant use is a global problem but in spite of its large prevalence and significant physical and psychological complications, there is inadequate literature on the management of inhalant dependence. Inhalants are also considered a substance of adolescence with most users giving up use in adulthood. There is also limited literature on co-occurring behavioral and substance addictions and the linkage between them. We describe the case of 28-year-old man who had been using toluene in a dependent pattern for 14 years. He also had problem gambling in the past, abstaining from which led to an increase in the daily quantity of use of toluene. The patient was tried on Carbabmazepine but following an adverse event he was prescribed Aripiprazole. He improved over the course of 6 weeks and has been abstaining from inhalants since 3 months.Keywords
This publication has 29 references indexed in Scilit:
- Inhalant Dependence: Data from a Tertiary Care Center in South IndiaIndian Journal of Psychological Medicine, 2012
- Volatile Substance Misuse in Mexico: Correlates and TrendsSubstance Use & Misuse, 2011
- Volatile Substance Misuse in the United StatesSubstance Use & Misuse, 2011
- InhalantsPediatrics in Review, 2008
- Inhalant abuse: A clinic-based studyIndian Journal of Psychiatry, 2008
- Effect of Aripiprazole, a Partial Dopamine D2 Receptor Agonist, on Increased Rate of Methamphetamine Self-Administration in Rats with Prolonged Session DurationNeuropsychopharmacology, 2007
- Inhalant use and disorders among adults in the United StatesDrug and Alcohol Dependence, 2006
- Aripiprazole in Schizophrenia With Cocaine DependenceJournal of Clinical Psychopharmacology, 2005
- Behavioral and Neurochemical Effects of 5-{4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide (EMD 68843): A Combined Selective Inhibitor of Serotonin Reuptake and 5-Hydroxytryptamine1A Receptor Partial AgonistThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Clinical Review of InhalantsThe American Journal on Addictions, 2001